Please login to the form below

Not currently logged in
Email:
Password:

Boehringer Ingelheim's Dr Susan Anton joins Icon

The CRO also appoints Dr Pui Leung, boosting its early phase and epidemiology and risk management teams

Icon has appointed former Boehringer Ingelheim director Dr Susan Anton to head up its epidemiology and risk management practice.

The move is one of two senior appointments at the contract research organisation (CRO), which also see Dr Pui Leung join at a senior clinical research physician.

Dr Anton has more than 25 years of experience leading international epidemiologic, health economic, and outcomes research, and other market access initiatives.

Most recently she served as director of US medical outcomes research and registries at Boehringer Ingelheim, and prior to that directed health economic, epidemiologic and outcomes research efforts across therapeutic areas at Bristol-Myers Squibb.

Meanwhile, Dr Leung, who will be based at Icon's clinical pharmacology unit in Manchester, UK, has 10 years of experience as a senior phase I clinical research physician in two UK CROs.

Before joining the pharmaceutical industry in 2002, he spent 13 years as a hospital physician in the UK's National Health Service (NHS).

22nd May 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics